ARCHIVES

Protocol Amendments Required For 98 NCI-Sponsored Trials

This article is from The Cancer Letter archive.

Vol. 36 No. 36 | October 8, 2010

Download PDF Visit The Full Archive

Related Articles

HHS Appeals Board Finds No Misconduct By Popovic

November 12, 1993

Urocidin May Provide Alternative To Cystectomy in BCG Cancers

May 27, 2011

DCBD Board Approves Recompetition Concepts, Including Cell Banks, Contrast Agents, Hepatoma Resources

November 14, 1980

Patient Groups Are Focus of New Alliances In a Shift of Cancer Advocacy Agenda

May 31, 1996

FDA Didn’t Punish Duke for Failing To Seek Proper Regulatory Clearance for Three Trials

January 27, 2012

Approval Granted For New Formulation of Lupron Depot

July 29, 2011